Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1541207
PUBLISHER: IMARC | PRODUCT CODE: 1541207
Nanomedicine Market Report by Nanomolecule Type, Product, Application, and Region 2024-2032
PUBLISHED:
PAGES: 147 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global nanomedicine market size reached US$ 263.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 719.5 Billion by 2032, exhibiting a growth rate (CAGR) of 11.4% during 2024-2032.
Nanomedicine refers to specialized multi-functional drugs with programmable properties used for the treatment of diseases and repairing tissues at a molecular level. It involves the use of nanoparticles, nanotubes and nanodevices, such as imaging agents, nanorobots, biochips and polymer therapeutics, for the diagnosis, treatment and prevention of a disorder and analyzing the underlying pathophysiology. The nanoparticles include metal and metal oxides, liposomes and inorganic particles, which are used for transporting the drugs and targeting difficult to reach areas in the body. As a result, nanomedicine finds extensive applications for drug delivery, diagnostic imaging, vaccines, regenerative medicines and implants.
Nanomedicine Market Trends:
The increasing prevalence of chronic medical ailments across the globe is one of the key factors creating a positive outlook for the market. Nanomedicine is highly beneficial in the treatment of oncological, neurological, urological, infectious, ophthalmological, orthopedic, immunological and cardiovascular diseases. In line with this, shifting preference for personalized medicines is also contributing to the growth of the market. Additionally, various technological advancements in the nanoscale technologies for improved diagnostic procedures are acting as other growth-inducing factors. Pharmaceutical manufacturers are using nanorobotic systems and other novel solutions for the effective administration of nanomedicines. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global nanomedicine market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on nanomolecule type, product and application.
Breakup by Nanomolecule Type:
Nanoparticles
Metal and Metal Oxide Nanoparticles
Liposomes
Polymers and Polymer Drug Conjugates
Hydrogel Nanoparticles
Dendrimers
Inorganic Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Breakup by Product:
Therapeutics
Regenerative Medicine
In-Vitro Diagnostics
In-Vivo Diagnostics
Vaccines
Breakup by Application:
Clinical Oncology
Infectious Diseases
Clinical Cardiology
Orthopedics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arrowhead Pharmaceuticals Inc., General Electric Company, Luminex Corporation, Merck & Co. Inc., Nanobiotix, Novartis AG, Pfizer Inc., Sanofi SA and Starpharma Holdings Limited.
Key Questions Answered in This Report
- 1. How big is the global nanomedicine market?
- 2. What is the expected growth rate of the global nanomedicine market during 2024-2032?
- 3. What are the key factors driving the global nanomedicine market?
- 4. What has been the impact of COVID-19 on the global nanomedicine market?
- 5. What is the breakup of the global nanomedicine market based on the nanomolecule type?
- 6. What is the breakup of the global nanomedicine market based on the product?
- 7. What is the breakup of the global nanomedicine market based on the application?
- 8. What are the key regions in the global nanomedicine market?
- 9. Who are the key players/companies in the global nanomedicine market?
Product Code: SR112024A4052
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Nanomedicine Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Nanomolecule Type
- 6.1 Nanoparticles
- 6.1.1 Market Trends
- 6.1.2 Major Types
- 6.1.2.1 Metal and Metal Oxide Nanoparticles
- 6.1.2.2 Liposomes
- 6.1.2.3 Polymers and Polymer Drug Conjugates
- 6.1.2.4 Hydrogel Nanoparticles
- 6.1.2.5 Dendrimers
- 6.1.2.6 Inorganic Nanoparticles
- 6.1.3 Market Forecast
- 6.2 Nanoshells
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Nanotubes
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Nanodevices
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Product
- 7.1 Therapeutics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Regenerative Medicine
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 In-Vitro Diagnostics
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 In-Vivo Diagnostics
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Vaccines
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Application
- 8.1 Clinical Oncology
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Infectious Diseases
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Clinical Cardiology
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Orthopedics
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Arrowhead Pharmaceuticals Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 General Electric Company
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.4 Luminex Corporation
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Merck & Co. Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Nanobiotix
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.7 Novartis AG
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Pfizer Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Sanofi SA
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Starpharma Holdings Limited
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.1 Abbott Laboratories
Product Code: SR112024A4052
List of Figures
- Figure 1: Global: Nanomedicine Market: Major Drivers and Challenges
- Figure 2: Global: Nanomedicine Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Nanomedicine Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Nanomedicine Market: Breakup by Nanomolecule Type (in %), 2023
- Figure 5: Global: Nanomedicine Market: Breakup by Product (in %), 2023
- Figure 6: Global: Nanomedicine Market: Breakup by Application (in %), 2023
- Figure 7: Global: Nanomedicine Market: Breakup by Region (in %), 2023
- Figure 8: Global: Nanomedicine (Nanoparticles) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Nanomedicine (Nanoparticles) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Nanomedicine (Nanoshells) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Nanomedicine (Nanoshells) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Nanomedicine (Nanotubes) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Nanomedicine (Nanotubes) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Nanomedicine (Nanodevices) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Nanomedicine (Nanodevices) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Nanomedicine (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Nanomedicine (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Nanomedicine (Regenerative Medicine) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Nanomedicine (Regenerative Medicine) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Nanomedicine (In-Vitro Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Nanomedicine (In-Vitro Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Nanomedicine (In-Vivo Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Nanomedicine (In-Vivo Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Nanomedicine (Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Nanomedicine (Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Nanomedicine (Clinical Oncology) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Nanomedicine (Clinical Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: Nanomedicine (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: Nanomedicine (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Global: Nanomedicine (Clinical Cardiology) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Global: Nanomedicine (Clinical Cardiology) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Global: Nanomedicine (Orthopedics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Global: Nanomedicine (Orthopedics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Global: Nanomedicine (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Global: Nanomedicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: North America: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: North America: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: United States: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: United States: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: Canada: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: Canada: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Asia-Pacific: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Asia-Pacific: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: China: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: China: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Japan: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Japan: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: India: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: India: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: South Korea: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: South Korea: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: Australia: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: Australia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Indonesia: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Indonesia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Others: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Europe: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Europe: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Germany: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Germany: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: France: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: France: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: United Kingdom: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: United Kingdom: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Italy: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Italy: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Spain: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Spain: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Russia: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Russia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Others: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Latin America: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Latin America: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Brazil: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Brazil: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 78: Mexico: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 79: Mexico: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 80: Others: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 81: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 82: Middle East and Africa: Nanomedicine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 83: Middle East and Africa: Nanomedicine Market: Breakup by Country (in %), 2023
- Figure 84: Middle East and Africa: Nanomedicine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 85: Global: Nanomedicine Industry: SWOT Analysis
- Figure 86: Global: Nanomedicine Industry: Value Chain Analysis
- Figure 87: Global: Nanomedicine Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Nanomedicine Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Nanomedicine Market Forecast: Breakup by Nanomolecule Type (in Million US$), 2024-2032
- Table 3: Global: Nanomedicine Market Forecast: Breakup by Product (in Million US$), 2024-2032
- Table 4: Global: Nanomedicine Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 5: Global: Nanomedicine Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Nanomedicine Market: Competitive Structure
- Table 7: Global: Nanomedicine Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.